NCT00424853 - ADVANCED Phase II Trial of Weekly vs 3 Weekly Docetaxel and Cisplatin Followed by Gemcitabine in Non-small-cell Lung Cancer (NSCLC) | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

May 31, 2005

Primary Completion Date

August 31, 2008

Study Completion Date

August 31, 2008

Conditions

Carcinoma, Non-Small-Cell Lung

Interventions

DRUG

Docetaxel and cisplatin followed by gemcitabine

docetaxel 75 mg/m2 day 1 + cisplatin 75 mg/m2 day1 repeated every 21 days for 3 cycles followed by gemcitabine 1200 mg/m2 day 1,8 repeated every 21 days for 3 cycles

DRUG

docetaxel and cisplatin followed by gemcitabine

docetaxel 25 mg/m2 day 1,8,15 + cisplatin 25 mg/m2 days1,8,15 repeated every 28 days for 3 cycles followed by gemcitabine 1200 mg/m2 day 1,8 repeated every 21 days for 3 cycles.

Trial Locations (1)

Unknown

Sanofi-Aventis Administrative Office, Milan